So far, 5 Americans are likely infected with monkeypox, the CDC said Monday. Health officials are trying to determine how the cases may be connected.
Author: Karen Weintraub, USA TODAY
After omicron winter surge, CDC finds nearly 60% of all Americans and 75% of kids have been infected by the coronavirus
By the end of February, nearly 60% of all Americans and 75% of kids had antibodies indicating a prior coronavirus infection, CDC study finds.
Why do my dogs smell like orange slices? The latest research on how COVID messes with smell
Most people hit early with coronavirus lost their smell. Now, not so much. Scientists are starting to figure out why and what that means.
Omicron’s new variant cousin, BA.2, has arrived in the US. But don’t panic yet, experts say.
Cases of omicron BA.2 have been reported in at least four states – California, New Mexico, Texas and Washington – and on three other continents.
Beyond Aduhelm: Why experts have never felt more optimistic about Alzheimer’s treatments
Even as the controversial new drug Aduhelm offers hope for those with Alzheimer’s, researchers are exploring new kinds of treatment approaches.
Treatment shortages, packed hospitals: Why at-risk adults should be on COVID alert
As omicron spreads, there’s a shortage of COVID-19 treatments, drugs and hospital beds, making those at high-risk for illness even more vulnerable.
‘My dad’s a fighter’: Man’s recovery exceeding expectations after receiving first heart from gene-edited pig
Dave Bennett, 57, who received the first heart transplant from a genetically modified pig, is breathing on his own, and speaking with a quiet voice.
The pandemic is changing. Will omicron bring a ‘new normal’ for COVID-19?
Experts say it’s too soon to know for sure what the coronavirus will do next, but one thing is clear: the world is going to have to live with COVID-19.
First pig-to-human heart transplant offers hope for thousands in need of organs
The breakthrough by doctors at the University of Maryland offers hope for those who languish on organ transplant waitlists.
Pfizer COVID-19 shot won’t be ready for youngest kids for months: ‘Might be a three-dose vaccine’
The lower dose given to 2- to 5-year-olds hasn’t produced the necessary immune protection in early tests, according to Pfizer.